SG11201608041QA - Triterpenoids with hiv maturation inhibitory activity, substituted in position 3 by a non-aromatic ring carrying a haloalkyl substituent - Google Patents

Triterpenoids with hiv maturation inhibitory activity, substituted in position 3 by a non-aromatic ring carrying a haloalkyl substituent

Info

Publication number
SG11201608041QA
SG11201608041QA SG11201608041QA SG11201608041QA SG11201608041QA SG 11201608041Q A SG11201608041Q A SG 11201608041QA SG 11201608041Q A SG11201608041Q A SG 11201608041QA SG 11201608041Q A SG11201608041Q A SG 11201608041QA SG 11201608041Q A SG11201608041Q A SG 11201608041QA
Authority
SG
Singapore
Prior art keywords
triterpenoids
substituted
aromatic ring
inhibitory activity
ring carrying
Prior art date
Application number
SG11201608041QA
Other languages
English (en)
Inventor
Sing-Yuen Sit
Yan Chen
Jie Chen
Jacob Swidorski
Brian Lee Venables
Ny Sin
Nicholas A Meanwell
Alicia Regueiro-Ren
Richard A Hartz
Li Xu
Zheng Liu
Original Assignee
Viiv Healthcare Uk No 4 Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=53002809&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG11201608041Q(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Viiv Healthcare Uk No 4 Ltd filed Critical Viiv Healthcare Uk No 4 Ltd
Publication of SG11201608041QA publication Critical patent/SG11201608041QA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J63/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008Expansion of ring D by one atom, e.g. D homo steroids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/63Esters of sulfonic acids
    • C07C309/64Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms
    • C07C309/65Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms of a saturated carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/63Esters of sulfonic acids
    • C07C309/64Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms
    • C07C309/65Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms of a saturated carbon skeleton
    • C07C309/66Methanesulfonates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/06Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D239/08Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms directly attached in position 2
    • C07D239/12Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D279/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/101,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/121,4-Thiazines; Hydrogenated 1,4-thiazines not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02Boron compounds
    • C07F5/025Boronic and borinic acid compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02Boron compounds
    • C07F5/04Esters of boric acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SG11201608041QA 2014-04-11 2015-04-09 Triterpenoids with hiv maturation inhibitory activity, substituted in position 3 by a non-aromatic ring carrying a haloalkyl substituent SG11201608041QA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201461978306P 2014-04-11 2014-04-11
PCT/US2015/025029 WO2015157483A1 (en) 2014-04-11 2015-04-09 Triterpenoids with hiv maturation inhibitory activity, substituted in position 3 by a non-aromatic ring carrying a haloalkyl substituent

Publications (1)

Publication Number Publication Date
SG11201608041QA true SG11201608041QA (en) 2016-10-28

Family

ID=53002809

Family Applications (2)

Application Number Title Priority Date Filing Date
SG11201608041QA SG11201608041QA (en) 2014-04-11 2015-04-09 Triterpenoids with hiv maturation inhibitory activity, substituted in position 3 by a non-aromatic ring carrying a haloalkyl substituent
SG10201709017PA SG10201709017PA (en) 2014-04-11 2015-04-09 Triterpenoids with hiv maturation inhibitory activity, substituted in position 3 by a non-aromatic ring carrying a haloalkyl substituent

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG10201709017PA SG10201709017PA (en) 2014-04-11 2015-04-09 Triterpenoids with hiv maturation inhibitory activity, substituted in position 3 by a non-aromatic ring carrying a haloalkyl substituent

Country Status (35)

Country Link
US (5) US9527882B2 (es)
EP (2) EP3129392B1 (es)
JP (1) JP6568202B2 (es)
KR (1) KR102411082B1 (es)
CN (1) CN106604909B (es)
AR (1) AR101077A1 (es)
AU (1) AU2015243500B2 (es)
BR (1) BR112016023414B1 (es)
CA (1) CA2944778C (es)
CL (1) CL2016002528A1 (es)
CR (1) CR20160472A (es)
CY (1) CY1123742T1 (es)
DK (1) DK3129392T3 (es)
DO (1) DOP2016000277A (es)
EA (1) EA030178B1 (es)
ES (1) ES2828705T3 (es)
HR (1) HRP20201645T1 (es)
HU (1) HUE051719T2 (es)
IL (1) IL248053B (es)
LT (1) LT3129392T (es)
MA (1) MA39374A1 (es)
MX (1) MX2016013425A (es)
NZ (1) NZ724644A (es)
PE (1) PE20161391A1 (es)
PH (1) PH12016501951A1 (es)
PL (1) PL3129392T3 (es)
PT (1) PT3129392T (es)
RS (1) RS60959B1 (es)
SG (2) SG11201608041QA (es)
SI (1) SI3129392T1 (es)
TW (1) TWI659964B (es)
UA (1) UA120927C2 (es)
UY (1) UY36070A (es)
WO (1) WO2015157483A1 (es)
ZA (1) ZA201606748B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE051719T2 (hu) 2014-04-11 2021-03-29 Viiv Healthcare Uk No 4 Ltd Triterpenoidok HIV érésgátló aktivitással, amelyek a 3-helyzetben egy halogénalkil-szubsztituenst hordozó nem-aromás gyûrûvel helyettesítettek
US20200268772A1 (en) * 2015-11-20 2020-08-27 ViiV Healthcare UK (No.4) Limited Hiv maturation inhibitor formulations
AR107512A1 (es) * 2016-02-04 2018-05-09 VIIV HEALTHCARE UK Nº 5 LTD Triterpenoides modificados en c-3 y c-17 como inhibidores del vih-1
JP2019528304A (ja) * 2016-08-31 2019-10-10 ヴィーブ ヘルスケア カンパニー 組み合わせ並びにその使用及び治療
PT3784349T (pt) 2018-04-24 2024-01-22 Viiv Healthcare Uk No 5 Ltd Compostos com atividade inibidora de maturação do hiv
SI3894424T1 (sl) * 2018-12-10 2023-04-28 Viiv Healthcare Uk (No. 4) Limited Mezilatna sol amino-lupanske spojine z zaviralno aktivnostjo dozorevanja HIV-a
CN109705189B (zh) * 2018-12-29 2020-06-05 中国医学科学院药用植物研究所 具有式i所示结构的三萜衍生物及其制备方法和应用
CN110981765A (zh) * 2019-11-07 2020-04-10 肇庆巨元生化有限公司 一种25-羟基维生素d3中间体的制备方法
WO2021116872A1 (en) * 2019-12-09 2021-06-17 Viiv Healthcare Company Pharmaceutical compositions comprising cabotegravir

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4906661A (en) 1981-11-12 1990-03-06 E. I. Du Pont De Nemours And Company Esters of aryloxypropanolamine derivatives
US5413999A (en) 1991-11-08 1995-05-09 Merck & Co., Inc. HIV protease inhibitors useful for the treatment of AIDS
US5679828A (en) 1995-06-05 1997-10-21 Biotech Research Labs, Inc. Betulinic acid and dihydrobetulinic acid derivatives and uses therefor
AR035311A1 (es) 1999-01-27 2004-05-12 Wyeth Corp Derivados de acido hidroxamico que contienen alquinilo, como inhibidores de las metalloproteinasas de matriz y de la tace, composicion farmaceutica y el uso de los mismos para la manufactura de un medicamento
US20040110785A1 (en) 2001-02-02 2004-06-10 Tao Wang Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
US7365221B2 (en) 2002-09-26 2008-04-29 Panacos Pharmaceuticals, Inc. Monoacylated betulin and dihydrobetulin derivatives, preparation thereof and use thereof
US7745625B2 (en) 2004-03-15 2010-06-29 Bristol-Myers Squibb Company Prodrugs of piperazine and substituted piperidine antiviral agents
EP1730163A4 (en) 2004-03-17 2009-12-30 Panacos Pharmaceuticals Inc Pharmaceutical salts of 3-O- (3,3-dimethylsuccinyl) betulinic acid
TW200628161A (en) 2004-11-12 2006-08-16 Panacos Pharmaceuticals Inc Novel betulin derivatives, preparation thereof and use thereof
US20090105203A1 (en) 2006-10-16 2009-04-23 Myriad Genetics, Incorporated Compounds for treating viral infections
EP2178376A4 (en) * 2007-08-03 2011-12-14 Advanced Life Sciences Inc LUPANIC TRITERPENOIDS MODIFIED IN 30-POSITION AND ITS ANALOG
WO2009100532A1 (en) 2008-02-14 2009-08-20 Virochem Pharma Inc. NOVEL 17ß LUPANE DERIVATIVES
US9067966B2 (en) 2009-07-14 2015-06-30 Hetero Research Foundation, Hetero Drugs Ltd. Lupeol-type triterpene derivatives as antivirals
PL2576586T3 (pl) 2010-06-04 2016-01-29 Bristol Myers Squibb Co C-28 amidy zmodyfikowanych pochodnych kwasu C-3 betulinowego jako inhibitory dojrzewania HIV
EA022393B1 (ru) * 2010-06-04 2015-12-30 Бристол-Майерс Сквибб Компани С-3 модифицированные производные бетулиновой кислоты в качестве ингибиторов созревания вич
EA022470B1 (ru) 2011-01-31 2016-01-29 Бристол-Маерс Сквибб Компани C-17 и c-3 модифицированные тритерпеноиды с ингибиторной активностью созревания вич
PL2670764T3 (pl) 2011-01-31 2016-02-29 Bristol Myers Squibb Co C-28 aminy zmodyfikowanych C-3 pochodnych kwasu betulinowego jako inhibitory dojrzewania HIV
US8906889B2 (en) * 2012-02-15 2014-12-09 Bristol-Myers Squibb Company C-3 cycloalkenyl triterpenoids with HIV maturation inhibitory activity
US8889854B2 (en) * 2012-05-07 2014-11-18 Bristol-Myers Squibb Company C-17 bicyclic amines of triterpenoids with HIV maturation inhibitory activity
HUE051719T2 (hu) 2014-04-11 2021-03-29 Viiv Healthcare Uk No 4 Ltd Triterpenoidok HIV érésgátló aktivitással, amelyek a 3-helyzetben egy halogénalkil-szubsztituenst hordozó nem-aromás gyûrûvel helyettesítettek

Also Published As

Publication number Publication date
HRP20201645T1 (hr) 2020-12-25
BR112016023414A2 (es) 2017-08-15
DOP2016000277A (es) 2017-02-28
EP3750910A1 (en) 2020-12-16
HUE051719T2 (hu) 2021-03-29
AR101077A1 (es) 2016-11-23
UA120927C2 (uk) 2020-03-10
US20170056420A1 (en) 2017-03-02
US20150291655A1 (en) 2015-10-15
US20170340650A1 (en) 2017-11-30
KR20160147809A (ko) 2016-12-23
US11464790B2 (en) 2022-10-11
LT3129392T (lt) 2020-11-10
CR20160472A (es) 2017-03-10
RS60959B1 (sr) 2020-11-30
ZA201606748B (en) 2018-05-30
ES2828705T3 (es) 2021-05-27
UY36070A (es) 2015-10-30
TWI659964B (zh) 2019-05-21
JP2017510659A (ja) 2017-04-13
AU2015243500A1 (en) 2016-10-27
US9527882B2 (en) 2016-12-27
MA39374A1 (fr) 2018-06-29
EP3129392B1 (en) 2020-08-05
PE20161391A1 (es) 2017-01-10
TW201623324A (zh) 2016-07-01
EA030178B1 (ru) 2018-06-29
US20200360404A1 (en) 2020-11-19
IL248053A0 (en) 2016-11-30
EA201691760A1 (ru) 2017-02-28
CA2944778A1 (en) 2015-10-15
CN106604909A (zh) 2017-04-26
US10245275B2 (en) 2019-04-02
CA2944778C (en) 2022-06-14
BR112016023414B1 (pt) 2022-09-13
US10780102B2 (en) 2020-09-22
PH12016501951B1 (en) 2017-01-09
US20190151336A1 (en) 2019-05-23
WO2015157483A1 (en) 2015-10-15
PH12016501951A1 (en) 2017-01-09
DK3129392T3 (da) 2020-10-19
EP3129392A1 (en) 2017-02-15
PT3129392T (pt) 2020-10-30
SG10201709017PA (en) 2017-11-29
NZ724644A (en) 2023-07-28
AU2015243500B2 (en) 2017-03-30
JP6568202B2 (ja) 2019-08-28
CY1123742T1 (el) 2022-03-24
KR102411082B1 (ko) 2022-06-17
CL2016002528A1 (es) 2017-06-23
MX2016013425A (es) 2017-05-02
PL3129392T3 (pl) 2021-04-06
SI3129392T1 (sl) 2020-11-30
IL248053B (en) 2020-04-30
CN106604909B (zh) 2019-02-15

Similar Documents

Publication Publication Date Title
ZA201606748B (en) Triterpenoids with hiv maturation inhibitory activity, substituted in position 3 by a non-aromatic ring carrying a haloalkyl substituent
ZA201704556B (en) Picolinamides with fungicidal activity
HK1219847A1 (zh) 手提箱,特別是登機手提箱
NL301260I2 (nl) Gefapixant, desgewenst in de vorm van een farmaceutisch aanvaardbaar zout.
HK1216557A1 (zh) 與模塊化搜索對象框架相關聯的基於意圖的搜索結果
IL240289A0 (en) c19-modified triterpenoids with HIV maturation inhibitory activity
GB201620546D0 (en) A distributed ledger
PL3230481T3 (pl) Stop ferrytyczny
ZA201900684B (en) A structural member
SG11201609559RA (en) Secure, motor-driven hinge to be provided on a humanoid robot
EP3237820C0 (en) REFRIGERATED SHELF SYSTEM
IL252132A0 (en) Pasta with a new shape
GB2548428B (en) Nondeterministic response to a challenge
FR3030149B1 (fr) Actionneur a encombrement reduit, avec conducteurs en s
FR3025844B1 (fr) Servovalve a tiroir composite
Lane Every Citizen Online: A Case Study
AU2015903959A0 (en) Dertermining feedback for reach-to-grasp movement performed by a user
TH1601000974B (th) เครื่องพ่นมีต้นกำลังสะพายหลัง
GB201405571D0 (en) P.o.o.n.t.a.n.g.i.n.g
ITTN20140008U1 (it) Alzalenzuolo, intercapedine formata da un arco per il letto
GB201313848D0 (en) R.i.l.a.s
AU2014903733A0 (en) A stud
AU2014900695A0 (en) A garment
ES1108082Y (es) Chancleta de dedo perfeccionada
GB201400218D0 (en) A sporicidal composition